<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: to examine the incidence rate of progression to Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and baseline prognostic risk factors, focusing on <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:chebi fb="0" ids="35674">antihypertensive</z:chebi> medication, in a cohort (n=207) with <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: after 2 and 4.6 (1 </plain></SENT>
<SENT sid="2" pm="."><plain>9-6.4) years new cases of <z:mp ids='MP_0002055'>diabetes</z:mp> were diagnosed by the oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test (OGTT) </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000822'>Hypertension</z:hpo> (BP 160/95 or <z:chebi fb="0" ids="35674">antihypertensive</z:chebi> medication) was included in multiple regression analyses to assess the effect of risk factors on the development of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:mp ids='MP_0002055'>diabetes</z:mp> developed in 32 subjects (19%), an incidence of 41/1000 (95% CI 28-57/1000) person-years </plain></SENT>
<SENT sid="5" pm="."><plain>In univariate analyses, progression to <z:mp ids='MP_0002055'>diabetes</z:mp> was associated with a high (&gt;9.0 mmol/l) 2-h OGTT value (P=0.008), a high fasting insulin (&gt;12.0 mU/l) level (P=0.000), a high <z:chebi fb="0" ids="17855">triglyceride</z:chebi> (&gt;/=1.3 mmol/l) level (P=0.028), a high BMI (&gt;/=28.0 kg/m(2)) (P=0.013) and <z:hpo ids='HP_0000822'>hypertension</z:hpo> (P=0.003) </plain></SENT>
<SENT sid="6" pm="."><plain>The risk for the development of <z:mp ids='MP_0002055'>diabetes</z:mp> was not increased in hypertensive subjects without <z:chebi fb="0" ids="35674">antihypertensive</z:chebi> medication compared with normotensive subjects (OR 0.8, 95% CI 0.3-2 </plain></SENT>
<SENT sid="7" pm="."><plain>6) </plain></SENT>
<SENT sid="8" pm="."><plain>However, it was increased in subjects with on medication, especially <z:chebi fb="40" ids="35498">diuretics</z:chebi> alone or in combination with other drugs </plain></SENT>
<SENT sid="9" pm="."><plain>Hypertensive subjects on <z:chebi fb="40" ids="35498">diuretics</z:chebi> had higher levels of fasting insulin and <z:chebi fb="4" ids="17855">triglycerides</z:chebi> and higher BMIs at baseline than normotensive subjects </plain></SENT>
<SENT sid="10" pm="."><plain>After adjustment for 2-h OGTT, fasting insulin, <z:chebi fb="4" ids="17855">triglycerides</z:chebi> and BMI, the OR for <z:mp ids='MP_0002055'>diabetes</z:mp> was 7.7 (95% CI 2.1-28.2) in hypertensive subjects using <z:chebi fb="40" ids="35498">diuretics</z:chebi> alone or in combination with other drugs and 2.6 (95% CI 1.0-6.7) in those using other drugs compared with normotensive subjects </plain></SENT>
<SENT sid="11" pm="."><plain>The OR of <z:mp ids='MP_0002055'>diabetes</z:mp> corresponding to a one-unit increase in the 2-h OGTT concentration was 2.5 (95% CI 1.6-4.0) in the whole cohort </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: the rate of progression from IGT to Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in this population was similar to that seen in other studies among Caucasian populations </plain></SENT>
<SENT sid="13" pm="."><plain>The use of <z:chebi fb="0" ids="35674">antihypertensive</z:chebi> medication, especially <z:chebi fb="40" ids="35498">diuretics</z:chebi>, and a high 2-h OGTT level were significant predictors of subsequent deterioration to <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>